eli lilly glp-1 agonist Lilly's Easy-to Use Once-Weekly Trulicity Approved in Europe Lilly Launches Trulicity in the

However, the study was small, and larger confirmatory studies have not been conducted

Mitigate most common GI side effects with starting low doses, escalating the dose slowly if needed, utilize anti-emetics and prokinetics as needed, eat fiber, maintain hydration, consider coordinating with psychiatrist/therapist, and anticipate need for insulin adjustment to prevent hypoglycemia

doi: 10.1007/s12020-024-03998-8

10.1016/S1474-4422(20)30173-3 Lancet Neurol

Over the 20th century, additional treatments were developed and FDA approved for treatment of overweight and obesity, including phentermine, phentermine/topiramate, orlistat, and naltrexone/bupropion